Granisetron Transdermal Patch

281 interactions 403 cited references

Also sold as: Sancuso Sancuso®

About Granisetron Transdermal Patch

Granisetron transdermal patches are used to prevent nausea and vomiting caused by chemotherapy. Granisetron is in a class of medications called 5HT3 inhibitors. It works by blocking serotonin, a natural substance in the body that causes nausea and vomiting. Read the full Granisetron Transdermal Patch drug information page →

Medically reviewed by Dr. Brian Staiger, PharmD, BCPS · Updated Aug 9, 2026 · Editorial policy · Data sources

Sources: FDA prescribing information (Structured Product Labeling), the published literature cited in each entry, DDInter 2.0 (a major open-access drug-interaction database), and legacy DrugBank interaction data distributed by the NIH's RxNav service (decommissioned in 2024) — analyzed and reviewed by our pharmacist team. How we build this library →

Most serious with: Phenelzine Pimozide Piperaquine Saquinavir Sparfloxacin Terfenadine

16 Contraindicated 265 Major

All (281) Contraindicated (16) Major (265)

Major

Granisetron Transdermal Patch Promethazine Phenadoz An increased risk of QT interval prolongation Details Granisetron Transdermal Patch Propafenone Rythmol Increased risk of QT interval prolongation Details Granisetron Transdermal Patch Protriptyline Increased risk of serotonin syndrome and QT-interval prolongation Details Granisetron Transdermal Patch Quetiapine Seroquel An increased risk of QT interval prolongation Details Granisetron Transdermal Patch Quinidine Cardioquin® An increased risk of QT interval prolongation Details Granisetron Transdermal Patch Quinine An increased risk of QT interval prolongation Details Granisetron Transdermal Patch Quizartinib Vanflyta An increased risk of QT interval prolongation Details Granisetron Transdermal Patch Ranolazine Aspruzyo An increased risk of QT interval prolongation Details Granisetron Transdermal Patch Rasagiline Azilect Increased risk of serotonin syndrome Details Granisetron Transdermal Patch Relugolix Orgovyx Increased risk of QT interval prolongation Details Granisetron Transdermal Patch Remifentanil Increased risk of serotonin syndrome Details Granisetron Transdermal Patch Revumenib Revuforj An increased risk of QT interval prolongation Details Granisetron Transdermal Patch Ribociclib Kisqali An increased risk of QT interval prolongation Details Granisetron Transdermal Patch Rilpivirine Edurant An increased risk of QT interval prolongation and torsade de pointes Details Granisetron Transdermal Patch Rizatriptan Increased risk of serotonin syndrome Details Granisetron Transdermal Patch Safinamide Xadago Increased risk of serotonin syndrome Details Granisetron Transdermal Patch Selegiline Anipryl Increased risk of serotonin syndrome Details Granisetron Transdermal Patch Selpercatinib Retevmo Increased risk of QT interval prolongation Details Granisetron Transdermal Patch Sertraline Increased risk of serotonin syndrome and an increased risk of QT interval prolongation Details Granisetron Transdermal Patch Sevoflurane Petrem Increased risk of QT interval prolongation Details Granisetron Transdermal Patch Sibutramine Increased risk of serotonin syndrome Details Granisetron Transdermal Patch Siponimod Mayzent An increased risk of QT interval prolongation Details Granisetron Transdermal Patch Sodium Phosphate OsmoPrep An increased risk of QT interval prolongation Details Granisetron Transdermal Patch Sodium Phosphate, Dibasic An increased risk of QT interval prolongation Details Granisetron Transdermal Patch Sodium Phosphate, Monobasic An increased risk of QT interval prolongation Details Granisetron Transdermal Patch Solifenacin Vesicare An increased risk of QT interval prolongation Details Granisetron Transdermal Patch Sorafenib Nexavar An increased risk of QT interval prolongation Details Granisetron Transdermal Patch Sotalol Betapace An increased risk of QT interval prolongation Details Granisetron Transdermal Patch St John's Wort Increased risk of serotonin syndrome Details Granisetron Transdermal Patch Sufentanil Dsuvia Increased risk of serotonin syndrome Details Granisetron Transdermal Patch Sulpiride An increased risk of QT interval prolongation Details Granisetron Transdermal Patch Sumatriptan Imitrex Increased risk of serotonin syndrome Details Granisetron Transdermal Patch Sunitinib Sutent An increased risk of QT interval prolongation Details Granisetron Transdermal Patch Tacrolimus Astagraf An increased risk of QT interval prolongation Details Granisetron Transdermal Patch Taletrectinib Ibtrozi Increased risk of QT interval prolongation and torsade de pointes Details Granisetron Transdermal Patch Tamoxifen Nolvadex® An increased risk of QT interval prolongation Details Granisetron Transdermal Patch Tapentadol Nucynta Increased risk of serotonin syndrome Details Granisetron Transdermal Patch Tedizolid Phosphate Sivextro An increased risk of serotonin syndrome Details Granisetron Transdermal Patch Telavancin Vibativ An increased risk of QT interval prolongation Details Granisetron Transdermal Patch Telithromycin Increased granisetron plasma concentrations and an increased risk of QT interval prolongation Details

Check another drug

Still have questions about this combination?

Every question gets a real answer from a licensed pharmacist — free, and usually within a day.

Ask the pharmacist

Educational information only, not medical advice. Always confirm interactions with your pharmacist or prescriber before making any change to your medications.